Australian Journal of Rural Health, Journal Year: 2024, Volume and Issue: 33(1)
Published: Dec. 31, 2024
Against the backdrop of alarming obesity rates and growing concerns about access to specialist care across Australia, this study aims assess utility nation's largest digital weight-loss service (DWLS) in regional Australia.
Language: Английский
Obesities, Journal Year: 2024, Volume and Issue: 4(3), P. 256 - 269
Published: July 24, 2024
Quality glucose-like peptide-1 receptor agonist (GLP-1 RA)-supported digital weight-loss services (DWLSs) have the potential to play a significant role in shifting alarming global obesity rate. Previous studies demonstrated various aspects of their utility Australian and British populations, but nothing has hitherto been investigated real-world European settings, where GLP-1 RA weight therapy healthcare are widely used. This study retrospectively analysed 5-month (Mean = 160.14 days) outcomes cohort patients who received email-based health coaching Semaglutide via Juniper Germany DWLS (n 833). Mean loss was 9.52 (±5.46) percent, with 81.51% losing ‘meaningful’ (5% or more) amount weight. Females 9.75) tended lose more than males 8.41) from lowest two BMI categories (27.5–29.99 kg/m2 10.1; 30–34.99 9.74) lost significantly those highest category (≥40 8.11). These findings indicate that RA-supported DWLSs can contribute meaningful Germany. Future research should seek conduct dedicated adherence analysis measure effect subsidisation baseline body mass index on general effectiveness.
Language: Английский
Citations
7
Published: July 1, 2024
Digital weight-loss services (DWLSs) combining pharmacotherapy and health coaching have the potential to make a major contribution global struggle against obesity. However, there is currently no evidence counter widespread concern that these enable large numbers of unsuitable patients obtain Glucagon-like peptide-1 receptor agonists (GLP-1 RA). This study retrospectively analysed rate at which partner pharmacy network Australia’s largest DWLS provider committed GLP-1 RA dispensing errors over 6-month period. The analysis found 191 (0.14%) 135131 dispensed Semaglutide orders contained an error. Non-compliant dose escalation (44.5%) dispatch (32.5%) were two most common error types. Most (89%) deemed been medium urgency, with 6.8% considered high urgency. A disproportionate number urgency cases from wrong medication (31%) general complaint (15%). Chi-square test revealed statistically higher among female (0.16%) compared males (0.076%). results lay important foundation in digital literature suggest comprehensive DWLSs safely collaborate third-party pharmacies RAs.
Language: Английский
Citations
3
Pharmacy, Journal Year: 2024, Volume and Issue: 12(5), P. 135 - 135
Published: Sept. 3, 2024
Digital weight-loss services (DWLSs) combining pharmacotherapy and health coaching have the potential to make a major contribution global struggle against obesity. However, degree which DWLSs compromise patient safety through dispensation of Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications is unknown. This study retrospectively analysed rate at patients reported GLP-1 RA dispensing errors from patient-selected partner pharmacies Australia's largest DWLS provider over six-month period. The analysis found that 99 (0.35%) 28,165 dispensed semaglutide orders contained an error. Incorrect dose (58.6%) unreasonable medication expiry window (21.2%) were two most common error types. Most (84.9%) deemed been medium urgency, with 11.1% being considered high-urgency errors. doses (45.5%) supplies wrong (36.3%) comprised in cases. Female more than male (0.41% vs. 0.12%,
Language: Английский
Citations
2
Healthcare, Journal Year: 2024, Volume and Issue: 12(20), P. 2093 - 2093
Published: Oct. 21, 2024
Digital weight loss services (DWLSs) that use Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated potential in contributing to a shift global obesity rates. However, reasonable concerns been raised about the prescribing safety of these services. Prior this study, electronic had only investigated hospital settings and community clinics.
Language: Английский
Citations
2
Telemedicine Reports, Journal Year: 2024, Volume and Issue: 5(1), P. 311 - 321
Published: April 1, 2024
Language: Английский
Citations
2
Cureus, Journal Year: 2024, Volume and Issue: unknown
Published: Nov. 23, 2024
Digital weight-loss services (DWLSs) that supplement continuous lifestyle coaching with semaglutide therapy have shown promise in delivering and effective obesity care. However, the extent to which design influences patient engagement program effectiveness is unknown. This study retrospectively analysed several markers weight loss percentage over 16 weeks a large semaglutide-supported DWLS UK (n=154). The comparative analysis found patients who received was proactive personalised sent statistically higher number of messages their health coach (Mean=19.37 vs Mean=8.55) opened app more frequently (Mean = 49.31 days Mean 40.06 days) than whose reactive standardised. 16-week 10.1% group compared 8.9% group, but difference not significant. A two-sample t-test female 9.76%) tended lose male 6.88%), (t(152) 1.89, p 0.04). findings add vital layers nuance emerging literature on DWLSs, indicating proactive, approach leads better engagement, such correlated short-term or adherence outcomes. Moreover, cohort's comparably mean relative previous real-world studies lend support advice leading global institutions using medication only as an adjunct multidisciplinary therapy. Investigators should expand this research by conducting comparable longer period medication-only control groups.
Language: Английский
Citations
2
Cureus, Journal Year: 2024, Volume and Issue: unknown
Published: Dec. 12, 2024
Digital modalities have been demonstrated to improve access and adherence various chronic care services by mitigating geographical, temporal, psychological barriers ongoing multidisciplinary consultations, which such diseases necessitate. The net utility of medication-supported digital weight-loss (DWLSs) has intensely debated over the past few years due their rapid uptake against backdrop obesity epidemic. However, research on these in real-world settings is scarce. Patients a large multinational DWLS were emailed four-question survey, soliciting reasons for using service instead face-to-face (F2F) alternatives. Responses collected from 1,283 patients, including 481 United Kingdom, 428 Germany, 374 Australia. Personal discomfort discussing weight loss F2F was most common reason subscribing Eucalyptus across full cohort (N = 557, 43.41%), followed modality's flexibility 441, 34.37%), patient inability comprehensive through local general practitioner (GP) 435, 33.90%), marketing or brand awareness 358, 27.90%). Several significant differences observed between country, gender, ethnicity, regular GP status each subscription reasons. This study contributed another important layer emerging literature DWLSs generating preliminary quantitative evidence benefits access. findings also indicated that certain number patients may be simply medications rather than care. To derive clearer conclusions about this concern, follow-up studies should aim analyze health coaching engagement markers range providers.
Language: Английский
Citations
1
Diabetes Obesity and Metabolism, Journal Year: 2024, Volume and Issue: 26(11), P. 4854 - 4863
Published: Sept. 2, 2024
To measure the effectiveness and sustainability of Juniper UK digital weight-loss service (DWLS), which delivers 6 months personalized, proactive lifestyle coaching supplemented with tirzepatide to patients through a multidisciplinary team (MDT).
Language: Английский
Citations
0
Australian Journal of Rural Health, Journal Year: 2024, Volume and Issue: 33(1)
Published: Dec. 31, 2024
Against the backdrop of alarming obesity rates and growing concerns about access to specialist care across Australia, this study aims assess utility nation's largest digital weight-loss service (DWLS) in regional Australia.
Language: Английский
Citations
0